FOR PREVIEWING & TESTING PURPOSES ONLY.
This notification will disappear once the page will be published.
This link is available for less than 30 minutes.
  • Easy to read
  • Text size
European Ombudsman
European Ombudsman

You have a complaint against an EU institution or body?

Make a complaint
Make a complaint
Current language: 
  • Nederlands
Source language: 
Available languages: 
The translation of this page has been generated by machine translation.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.

Gedeeltelijke weigering om het publiek toegang te verlenen tot verslagen van klinische studies met betrekking tot de goedkeuring van een geneesmiddel (Humira) voor de behandeling van de ziekte van Crohn

Case opened
Case OI/3/2014/FOR - Opened on Wednesday | 16 April 2014 - Decision on Wednesday | 08 June 2016 - Institution concerned European Medicines Agency ( No further inquiries justified ) - Country France

Gedeeltelijke weigering om het publiek toegang te verlenen tot verslagen van klinische studies met betrekking tot de goedkeuring
van een geneesmiddel (Humira) voor de behandeling van de ziekte van Crohn

What did you think of this automatic translation? Give us your opinion!

Related documents